GSDME and neoplasm: Active caspase-3 drives pyroptosis of GSDME-positive tumour cells and release of alarmins that activate caspase-1 and GSDMD in neighbouring macrophages, finally resulting in macrophage-driven release of pro-inflammatory cytokines and CRS.